Danielle A. Wagner
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses, Animal Virus Infections Studies, SARS-CoV-2 detection and testing
Most-Cited Works
- → mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron(2022)225 cited
- → Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants(2021)213 cited
- → Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates(2021)104 cited
- → Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung(2021)82 cited
- → mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron(2022)51 cited
- → High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19(2021)48 cited
- → Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity(2018)40 cited
- → Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones(2022)36 cited
- → Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague(2019)33 cited
- → Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants(2021)29 cited